FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3130309 · Received May 24, 2013

Report

Report Number
1416980-2013-13387
Event Type
Injury
Date Received
May 24, 2013
Date of Event
April 29, 2013
Report Date
May 2, 2013
Manufacturer
BAXTER HEALTHCARE
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENT EXPERIENCED ASEPTIC PERITONITIS DUE TO PEPTIDOGLYCAN DURING THE FIRST EXCHANGE OF THE DAY NOT REQUIRING HOSPITALIZATION. THE PATIENT WAS ASYMPTOMATIC AND REMEDIAL MEDICATION WAS NOT REQUIRED. ON AN UNREPORTED DATE, EXTRANEAL WAS PERMANENTLY DISCONTINUED DUE TO THE PERITONITIS. THE PATIENT RECOVERED FROM THIS PERITONITIS EVENT.

Description of Event or Problem · 1

THIS IS A REPORT OF SUSPECTED PERITONITIS IN A PATIENT COINCIDENT WITH EXTRANEAL THERAPY FOR PERITONEAL DIALYSIS (PD). IT WAS NOT REPORTED IF EXTRANEAL THERAPY WAS ONGOING. TREATMENT WAS NOT REPORTED. THE ROOT CAUSE OF THE SUSPECTED PERITONITIS WAS NOT REPORTED. THE OUTCOME OF THIS PERITONITIS EVENT WAS NOT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
231415 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE

Patients

Seq Age Sex Outcome Treatment
1 67 YR Other ATENOLOL, MANIDIPINE, DOXAZOSIN GITS, ATORVASTATIN| ACETYLSALICYLIC ACID, LANTHANUM CARBONATE| CINACALCET, FOLIC ACID, EPOETIN| EXTRANEAL